October trial date set in Parachute sex assault case
May 8, 2014
Shawn Angell, 44, will stand trial this fall for an alleged sexual assault in the spring of last year.
Early in the morning of March 24, 2013, police were dispatched to home outside Parachute after a woman reported that a man had “broken into her home, hit her over the head, shocked her, and then raped her,” according to the arrest affidavit in the case.
Deputies from the Garfield County Sheriff’s Office canvassed the area based on the woman’s description and spoke to several neighbors.
Angell was subsequently arrested, and a search of his home yielded a stun gun as well as a pair of women’s underwear, which were later alleged to belong to the victim.
He was charged with second degree kidnapping (a class two felony), sex assault by force (a class three felony), first degree burglary (a class three felony), tampering with physical evidence (a class six felony), first degree criminal trespass (a class six felony), use of a stun gun in commission of a crime (a class six felony), as well as misdemeanor third degree assault and child abuse.
He has been held at the Garfield County Jail on a $1 million bond since.
Angell initially pleaded not guilty but changed his plea to not guilty by reason of insanity. His original February trial date was postponed, and on Friday, Angell appeared before District Judge Daniel Petre in order to set a new trial date.
Before a date could be set, Petre responded to a motion by Deputy 9th District Attorney Steve Mallory that requested additional medical and psychological information from the defense. Petre subsequently ordered the release of a doctor’s report under seal that the court took a recess to review.
Deputy Public Defender Sarah Steele told the court that Angell had surgery for a brain tumor in his frontal lobe and has since experienced personality changes as well as auditory and visual hallucinations.
“There is an issue here. It is based in the facts. It has been noted by both doctors,” she said.
Judge Petre added the requirement that Angell undergo neuropsychological testing prior to trial, pushing the trial’s start date back to Oct. 27.